Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains.
Recently, two cell surface molecules, CD46 and moesin, have been found to be functionally associated with measles virus (MV) infectivity of cells. We investigated the receptor usage of MV wild-type, subacute sclerosing panencephalitis, and vaccine strains and their effect on the down-regulation of CD46 after infection. We found that the infection of human cell lines with all 19 MV strains tested was inhibitable with antibodies against CD46. In contrast, not all strains of MV led to the downregulation of CD46 following infection. The group of CD46 non-downregulating strains comprised four lymphotropic wild-type isolates designated AB, DF, DL, and WTF. Since the downregulation of CD46 is caused by interaction with newly synthesized MV hemagglutinin (MV-H), we tested the capability of recombinant MV-H proteins to downregulate CD46. Recombinant MV-H proteins of MV strains Edmonston, Halle, and CM led to the down-regulation of CD46, whereas those of DL and WTF did not. This observed differential downregulation by different MV strains has profound consequences, since lack of CD46 on the cell surface leads to susceptibility of cells to complement lysis. These results suggest that lymphotropic wild-type strains of MV which do not downregulate CD46 may have an advantage for replication in vivo. The relatively weak immune response against attenuated vaccine strains of MV compared with wild-type strains might be related to this phenomenon.
Schneider-Schaulies
J
J
Institut für Virologie und Immunbiologie, W urzburg, Germany.
Schnorr
J J
JJ
Brinckmann
U
U
Dunster
L M
LM
Baczko
K
K
Liebert
U G
UG
Schneider-Schaulies
S
S
ter Meulen
V
V
D000818:Animals; D000906:Antibodies; D000911:Antibodies, Monoclonal; D015703:Antigens, CD / Q000276:immunology / Q000502:physiology*; D002460:Cell Line; D002522:Chlorocebus aethiops; D006367:HeLa Cells; D006389:Hemagglutinins, Viral / Q000276:immunology; D006801:Humans; D008214:Lymphocytes / Q000276:immunology* / Q000821:virology*; D008458:Measles Vaccine / Q000276:immunology* / Q000378:metabolism; D008459:Measles virus / Q000276:immunology / Q000502:physiology*; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000276:immunology / Q000502:physiology*; D011991:Receptors, Virus / Q000502:physiology*; D013045:Species Specificity; D014709:Vero Cells; D014779:Virus Replication
D000906:Antibodies; D000911:Antibodies, Monoclonal; D015703:Antigens, CD; C497857:CD46 protein, human; D006389:Hemagglutinins, Viral; D008458:Measles Vaccine; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; D011991:Receptors, Virus